Interleukin-10 as an explanation for pregnancy-induced flare in systemic lupus erythematosus and remission in rheumatoid arthritis

Rheumatology

Volumn 38, Issue 6, 1999, Pages 496-498

  Huizinga, T W J ^a   Van Der Linden, M W ^a   Deneys Laporte, V ^b   Breedveld, F C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

DISEASE ACTIVITY; FEMALE; HUMAN; IMMUNOMODULATION; PREGNANCY; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; REMISSION, SPONTANEOUS;

EID: 0032701225     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.6.496     Document Type: Short Survey

References (29)

1. Ruiz-Isasorza G, Lima F, Alves J, Khumashta MA, Simpson J, Hughes GRV et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 58 pregnancies. Br J Rheumatol 1996;35:133-83.
2. Nelson JL, Oslensen M. Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am 1997;23:195-212.
3. Hench PS, Kendall EC, Slocumb CH, Policy HF. The effect of a hormone of the adrenal cortex and of pituitary ACTH on rheumatoid arthritis. Proc Mayo Clin 1949;24:181-98.
4. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997;18:478-82.
5. Lin H, Mossman TR, Guilbert S, Tuntipopitat S, Wegemann TG. Synthesis of TH2 cytokines at the maternal fetal interface. J Immunol 1993;151:4562-8.
6. Keleman K, Paldi A, Tinneberg H, Torok A, Szekesesbartho J. Early recognition of pregnancy by the maternal immune system. Am J Reprod Immunol 1998;39:351-5.
7. Chaout G, Menu E, De Smedt D, Krihnan L, Hui L, Meliani A et al. The emerging role of IL10 in pregnancy. Am J Reprod Immunol 1996;35:325-9.
8. Groux H, O'Garra A, Bigler M et al. A CD4 T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-2.
9. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996;106:127-33.
10. Llorente L, Palin YR, Couderc J, Alarcon-Segovia D, Ruiz-Soto R, Alcocer-Castillejos N et al. Dysregulation of IL10 production in relatives of patients with SLE. Arthritis Rheum 1997;40:1429-35.
11. Llorente L, Richaudpatin Y, Fior R et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus - A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 1994;37:1647-55.
12. Llorente L, Zou WP, Levy Y et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995;181:839-44.
13. Hagiwara E, Gourley MF, Lee S, Klinman DM. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: Interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum 1996;39:379-85.
14. Paik YB, Lee J, Lee CH. Elevated IL10 correlated with disease activity in SLE. Arthritis Rheum 1996;39:S250.
15. Van der Linden MW, Westendorp RGJ, Sturk A, Stocken DJ, Vandenbroucke JP, Breedveld FC et al. Innate high IL10 production is associated with susceptibility for SLE. Arthritis Rheum 1997;40:S1656.
16. Grönda G, Kristjansdottir H, Gunnlaugsdottir B, Arnason A, Alarcon-Riquelme ME, Lundberg I et al. Increased number of IL10 producing cells in SLE patients and their first degree relatives in Icelandic multicase families. Arthritis Rheum 1997;40:S1657.
17. Mongan AE, Ramhadin S, Warrinton RJ. IL10 response abnormalities in SLE. Scand J Immunol 1997;46:406-12.
18. Eskdale J, Gallagher G, Verweij C, Keijsers V, Westendorp R, Huizinga T. IL10 secretion in relation to the haplotypic structure of the human IL10 locus. Proc Natl Acad Sci USA 1998;95:9465-70.
19. Eskdale J, Wordsworth P, Bouman S, Field M, Gallagher G. Association between polymorphisms at the human IL10 locus and SLE. Tissue Antigens 1997;49:635-9.
20. Mehrian R, Quismorio FP, Strassmann G, Stimmler MM, Horwitz DA, Kitridov RC et al. Synergistic effect between IL10 and Bcl 2 genotypes in determining susceptibility to SLE. Arthritis Rheum 1998;41:596-602.
21. Mor CC, Lanchbury JS, Chan DW, Lav CS. IL10 promoter polymorphisms in Southern Chinese patients with SLE. Arthritis Rheum 1998;41:1090-5.
22. Horowitz D, Gray JD, Ohtsoka K. Regulation of TGFβ1 produced by human blood mononuclear cells by mitogens and cytokines. Arthritis Rheum 1996;39:S251.
23. Dang H, Geiser AG, Letterio JJ et al. SLE-like autoantibodies and Sjogren's Syndrome-like lymphoproliferation in TGF-beta knockout mice. J Immunol 1995; 155:3205-12.
24. Peng SL, Moslehi J, Craft J. Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest 1997;99:1936-46.
25. Takahashi S, Fossati L, Iwamoto M et al. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 1996;97:1597-604.
26. Feldman M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14:397-440.
27. Sugiyama E, Kuroda A, Taki H et al. Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol 1995;22:2020-6.
28. Isomaki P, Luukkainen R, Saario R, Toivanen P, Punnonen J. Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum 1996;39:386-95.
29. Maini RN, Paulus H, Breedveld FC, Moreland LW, St Clair WE, Russem AS et al. Rhu IL10 in subjects with active RA: a phase I and cytokine response study. Arthritis Rheum 1997;40:S1161.